Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

businesswire.com
ABCL AbCellera announced its participation in the J.P. Morgan Healthcare Conference. The article provides factual information about the event and the company's focus areas without indicating positive or negative performance.

VANCOUVER, British Columbia--( BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that the Company will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026.

A live audio webcast of the presentation may be accessed through a link that will be posted on AbCellera's Investor Relations website. A replay will be available through the same link following the presentation.

About AbCellera Biologics Inc.

AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visit www.abcellera.com.